Nitrogen

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for use in specific medical situations where the administration of Nitrogen is deemed necessary. It is essential that this drug be administered only by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrogen. The practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Limitations of use include the potential hazards associated with Nitrogen administration, which may contraindicate its use in certain patients or conditions. There are no reported teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Administration of Nitrogen is associated with potential hazards and contraindications. It is intended for use solely by or under the supervision of a licensed practitioner who possesses experience in the use and administration of Nitrogen. This practitioner must be well-versed in the indications, effects, dosages, methods, and frequency and duration of administration.

The route of administration for Nitrogen is via respiratory inhalation. It is imperative that healthcare professionals adhere to established protocols and guidelines when administering this substance to ensure patient safety and therapeutic efficacy.

Contraindications

Administration of Nitrogen is contraindicated in situations where safety precautions have not been fully understood or implemented. It is intended for use only by or under the supervision of a licensed practitioner experienced in its administration, who is knowledgeable about its indications, effects, dosages, methods, frequency, duration, hazards, contraindications, side effects, and necessary precautions.

Additionally, Nitrogen should not be handled until all safety precautions have been read and understood. It must be used and stored exclusively outdoors or in a well-ventilated area. Connections should not be changed or forced, and the valve must be closed after each use and when the container is empty. The container should always be maintained in an upright position to ensure safety.

Warnings and Precautions

Use and storage of the product must be conducted exclusively outdoors or in a well-ventilated area to minimize the risk of inhalation and ensure safety. It is imperative to utilize a backflow preventive device in the piping to prevent any potential hazards associated with gas backflow. The equipment employed must be rated for cylinder pressure to ensure compatibility and safety during use.

After each use, and when the cylinder is empty, the valve should be securely closed to prevent accidental release of the contents. Additionally, the product must be protected from sunlight, particularly when ambient temperatures exceed 52°C (125°F), as exposure to high temperatures may compromise safety.

Prior to use, healthcare professionals are strongly advised to read and adhere to the Safety Data Sheet (SDS) to understand the risks and safety measures associated with the product.

In the event of inhalation, it is crucial to remove the affected individual from the exposure source and ensure they are in a comfortable position for breathing. Medical advice or attention should be sought immediately to address any potential health concerns.

Currently, there are no specific laboratory tests recommended for monitoring the use of this product. However, healthcare professionals should remain vigilant and responsive to any adverse effects that may arise during its use.

Side Effects

Patients may experience a range of adverse reactions associated with the use of nitrogen. Serious respiratory effects can occur, including hypoxia, asphyxia, and respiratory depression. These conditions may lead to significant health risks, including serious injury or death if nitrogen is inhaled in high concentrations, as highlighted in the boxed warning.

Commonly reported non-serious adverse reactions include dizziness, headache, nausea, and vomiting. It is crucial for patients to use nitrogen only in well-ventilated areas to mitigate the risk of hypoxia and to avoid exposure to high concentrations of nitrogen gas. Monitoring for these adverse reactions is essential to ensure patient safety and to address any potential complications promptly.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrogen, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Administration of Nitrogen in pediatric patients may pose hazards or be contraindicated. It is essential that Nitrogen is used only by or under the supervision of a licensed practitioner who possesses experience in its use and administration. This practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions. Careful consideration and adherence to these guidelines are critical to ensure the safety and efficacy of Nitrogen in pediatric populations.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The administration of Nitrogen during pregnancy may pose potential risks, and its use is contraindicated or hazardous. There is no specific information available regarding the safety of Nitrogen in pregnant patients, including any known fetal impacts or outcomes. Due to the lack of data on dosage modifications or special precautions for use during pregnancy, it is essential that Nitrogen be administered only by or under the supervision of a licensed practitioner experienced in its use. Healthcare professionals should carefully consider the potential risks and benefits before recommending Nitrogen to women of childbearing potential.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or its effects during lactation. Healthcare professionals should consider the lack of data when advising lactating mothers about the use of this medication. It is recommended to weigh the potential benefits against any unknown risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert text regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients, although specific recommendations are not provided.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of Nitrogen NF. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for this population. It is recommended that healthcare providers exercise caution when prescribing Nitrogen NF to patients with compromised liver function, given the lack of data on its safety and efficacy in this group. Regular monitoring of liver function may be prudent in these patients, although specific parameters are not outlined in the prescribing information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may arise from an overdose. Common symptoms may include, but are not limited to, severe drowsiness, confusion, respiratory distress, or any other unusual clinical manifestations.

Management of an overdose should be tailored to the individual patient and may involve supportive care, including monitoring vital signs and providing symptomatic treatment as necessary. In cases of significant overdose, consultation with a poison control center or a medical toxicologist is recommended to determine the most appropriate course of action.

It is crucial for healthcare professionals to educate patients about the importance of adhering to prescribed dosages and to provide guidance on what to do in the event of a suspected overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No specific postmarketing experience details are available in the provided text. As such, there are no reported adverse events or case reports to summarize.

Patient Counseling

Healthcare providers should advise patients that the administration of Nitrogen may pose hazards or be contraindicated. It is essential that Nitrogen is used only by or under the supervision of a licensed practitioner who possesses experience in its use and administration. This practitioner should be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Providers must emphasize the warning that Nitrogen contains refrigerated gas, which may lead to cryogenic burns or injury. Additionally, it may displace oxygen, resulting in rapid suffocation. Patients should be instructed not to handle Nitrogen until they have read and fully understood all safety precautions.

It is crucial to inform patients that Nitrogen should only be used and stored outdoors or in a well-ventilated area. They should be advised to wear appropriate protective gear, including cold insulating gloves, a face shield, and eye protection. The use of a backflow preventive device in the piping is also recommended.

Patients must be cautioned against changing or forcing connections, and they should be instructed to close the valve after each use and when the container is empty. It is important to always keep the container in an upright position and to read and follow the Safety Data Sheet (SDS) prior to use.

In the event of an emergency, healthcare providers should inform patients of the first aid measures to take. If Nitrogen is inhaled, the individual should be removed to a comfortable position for breathing. If Nitrogen comes into contact with the skin, patients should thaw any frosted areas with lukewarm water without rubbing the affected area and seek immediate medical advice or attention.

Storage and Handling

The product is available in various package configurations, with specific NDC numbers assigned for identification. Storage and handling instructions are not explicitly provided; therefore, standard practices for pharmaceutical products should be followed. It is advisable to store the product in a controlled environment, ensuring that it is kept at appropriate temperatures to maintain its integrity and efficacy. Containers should be kept sealed and protected from light and moisture to prevent degradation. Special handling requirements are not specified, but general precautions should be taken to ensure the product's quality is preserved throughout its shelf life.

Additional Clinical Information

No further data are available.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrogen as submitted by Norco, Inc. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)